Does the number of circulating platelets influence the postoperative evolution of endometrial cancer?

Endometrial cancer is a frequently encountered gynecologic malignancy with increasing incidence; in order to maximize the chances to achieve a long-term survival rate, attention was focused on better identifying the patients at risk to develop more aggressive forms of the disease. The aim of the current paper is to investigate the influence of the number of circulating platelets alone or in association with other biomarkers on the perioperative outcomes of endometrial cancer patients.